Evaluating the risks and benefits of phase II and III cancer clinical trials: a look at Institutional Review Board members in the Netherlands.
作者信息
Van Luijn H E M, Musschenga A W, Keus R B, Aaronson N K
机构信息
Department of Philosophy, Vrije Universiteit, Amsterdam, The Netherlands.
出版信息
IRB. 2007 Jan-Feb;29(1):13-8.
PMID:17855839
Abstract
摘要
Zotero 插件